1.51
+0.05(+3.42%)
Currency In USD
Address
500 College Road East
Princeton, NJ 08540
United States of America
Phone
609 683 1880
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
19
First IPO Date
May 23, 2014
| Name | Title | Pay | Year Born |
| Mr. Alfred F. Altomari | Chairman, President & Chief Executive Officer | 646,532 | 1959 |
| Mr. Scott M. Coiante | Chief Financial Officer, Senior Vice President & Treasurer | 436,913 | 1967 |
| Mr. Robert G. Conway M.E. | Senior Vice President and Chief Corporate Planning & Supply Chain Officer | 444,112 | 1957 |
| Dr. Paul Korner M.B.A., M.D. | Senior Vice President & Chief Medical Officer | 494,596 | 1966 |
| Mr. Geoffrey P. Gilmore | Senior Vice President, Chief Administrative Officer & Corporate Secretary | 494,851 | 1966 |
| Ms. Amy Welsh | Senior Vice President & Chief Commercial Officer | 0 | 1971 |
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.